Trident Lifeline

₹169 -6.8 | 3.8%

WEBSITE BSE:543616 NSE : TLL 18 May, 10:00

Market Cap ₹194 Cr.

Stock P/E 30.3

P/B 4.2

Current Price ₹169

Book Value ₹ 40.6

Face Value 10

52W High ₹239.7

Dividend Yield 0%

52W Low ₹ 128.3

Edit Ratio

Trident Lifeline Research see more...

Overview Inc. Year: 2014Industry: Pharmaceuticals & Drugs

Trident Lifeline Ltd is a dynamic and innovative healthcare company focused on revolutionizing medical solutions. With a commitment to enhancing lives, Trident Lifeline specializes in cutting-edge medical devices, diagnostics, and personalized health technologies. The company's extensive research and development efforts drive breakthroughs in patient care, preventive medicine, and telehealth solutions. Trident Lifeline's dedicated team of experts collaborates with medical professionals to create groundbreaking products that empower individuals to take control of their well-being. By seamlessly merging technology and healthcare, Trident Lifeline aims to provide accessible, high-quality medical advancements that contribute to a healthier and more connected world.

Trident Lifeline Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Trident Lifeline Quarterly Results

#(Fig in Cr.)	Mar 2022	Jun 2022	Dec 2022	Mar 2023	Jun 2023
Net Sales	9	6	9	8	9
Other Income	0	0	0	1	0
Total Income	9	6	10	9	9
Total Expenditure	7	5	7	7	7
Operating Profit	2	1	2	3	2
Interest	0	0	0	0	0
Depreciation	0	0	0	0	0
Exceptional Income / Expenses	0	0	0	0	0
Profit Before Tax	2	1	2	2	2
Provision for Tax	-1	0	0	0	0
Profit After Tax	3	1	2	2	1
Adjustments	0	0	0	0	0
Profit After Adjustments	3	1	2	2	1
Adjusted Earnings Per Share	3.5	0.9	1.8	1.7	1.2

Trident Lifeline Profit & Loss

#(Fig in Cr.)	Mar 2022	Mar 2023	TTM
Net Sales	22	32	32
Other Income	1	1	1
Total Income	22	33	34
Total Expenditure	19	25	26
Operating Profit	3	7	8
Interest	0	0	0
Depreciation	0	0	0
Exceptional Income / Expenses	0	0	0
Profit Before Tax	3	7	7
Provision for Tax	-1	1	0
Profit After Tax	4	6	6
Adjustments	0	0	0
Profit After Adjustments	4	6	6
Adjusted Earnings Per Share	4.9	5.2	5.6

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	45%	0%	0%	0%
Operating Profit CAGR	133%	0%	0%	0%
PAT CAGR	50%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	20%	NA%	NA%	NA%
ROE Average	24%	54%	54%	54%
ROCE Average	24%	34%	34%	34%

Trident Lifeline Balance Sheet

#(Fig in Cr.)	Mar 2022	Mar 2023
Shareholder's Funds	5	46
Minority's Interest	0	0
Borrowings	1	2
Other Non-Current Liabilities	-1	-0
Total Current Liabilities	8	11
Total Liabilities	13	59
Fixed Assets	1	3
Other Non-Current Assets	1	6
Total Current Assets	11	49
Total Assets	13	59

Trident Lifeline Cash Flow

#(Fig in Cr.)	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	0
Cash Flow from Operating Activities	-0	-17
Cash Flow from Investing Activities	-0	-7
Cash Flow from Financing Activities	1	38
Net Cash Inflow / Outflow	0	14
Closing Cash & Cash Equivalent	0	14

Trident Lifeline Ratios

#	Mar 2022	Mar 2023
Earnings Per Share (Rs)	4.93	5.23
CEPS(Rs)	5.19	5.55
DPS(Rs)	0	0
Book NAV/Share(Rs)	5.93	39.38
Core EBITDA Margin(%)	12.44	19.77
EBIT Margin(%)	14.28	22.28
Pre Tax Margin(%)	13.71	20.76
PAT Margin (%)	18.14	18.98
Cash Profit Margin (%)	19.07	20.13
ROA(%)	30.72	16.83
ROE(%)	83.23	24.05
ROCE(%)	43.21	24.32
Receivable days	83.27	98.38
Inventory Days	62.24	62.65
Payable days	177.25	111.7
PER(x)	0	30.41
Price/Book(x)	0	4.04
Dividend Yield(%)	0	0
EV/Net Sales(x)	0.47	5.51
EV/Core EBITDA(x)	3.11	23.54
Net Sales Growth(%)	0	45.59
EBIT Growth(%)	0	127.04
PAT Growth(%)	0	52.37
EPS Growth(%)	0	6.01
Debt/Equity(x)	0.52	0.12
Current Ratio(x)	1.41	4.33
Quick Ratio(x)	0.92	3.7
Interest Cover(x)	24.72	14.66
Total Debt/Mcap(x)	0	0.03

Trident Lifeline Shareholding Pattern

#	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	69.57	69.85	69.99	70.04	70.04	70.04	67.48
FII	2.94	4.2	4.39	4.36	4.64	4.64	6.02
DII	0	0	0	0	0	0	0
Public	27.49	25.95	25.62	25.6	25.32	25.32	26.5
Others	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100

#	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.8	0.8	0.8	0.81	0.81	0.81	0.78
FII	0.03	0.05	0.05	0.05	0.05	0.05	0.07
DII	0	0	0	0	0	0	0
Public	0.32	0.3	0.29	0.29	0.29	0.29	0.3
Others	0	0	0	0	0	0	0
Total	1.15	1.15	1.15	1.15	1.15	1.15	1.15

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 54%
Debtor days have improved from 177.25 to 111.7days.
Company is almost debt free.

Cons

Stock is trading at 4.2 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Trident Lifeline News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Trident Lifeline

Add Watchlist

Trident Lifeline Research see more...

Overview Inc. Year: 2014Industry: Pharmaceuticals & Drugs

Trident Lifeline Share Price

Alert Data

Quarterly Price

Peer Comparison

Trident Lifeline Quarterly Results

Trident Lifeline Profit & Loss

Growth Rates

Trident Lifeline Balance Sheet

Trident Lifeline Cash Flow

Trident Lifeline Ratios

Trident Lifeline Shareholding Pattern

Trident Lifeline News

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!